Under the agreement, Symbollon will transfer ownership of its patent application covering use of its technology in the upper respiratory tract. As partial consideration under the agreement, Symbollon
CS-866AZ is a combination drug of the long-acting calcium channel blocker azelnidipine (Calblock jointly researched and developed by Daiichi Sankyo and its partner Ube Industries) and the high
According to the company, Mario Polywka, COO, and Klaus Maleck, CFO, will jointly lead the organization until a permanent successor is announced. Flemming Ornskov, chairman of the supervisory
Vascular Pathways’s (VPI’s) technology uses a retractable nitinol guidewire system which Telesso anticipates will result in faster and more reliable peripheral IV placement with less patient discomfort. Telesso
The collaboration is based on new data that the University of California, San Francisco (UCSF) scientists, along with collaborators, published in the journal Nature suggesting that GNAQ plays
The parties have established a framework for the discovery, development and commercialization of diagnostic tests. Financial terms of the agreement were not disclosed. The collaboration is said to
Under the terms of the agreement extension, Mentor retains exclusive distribution rights for Lysonix in the US and gains non-exclusive rights for certain foreign markets. Minimum purchase requirements
The Conix technology platform includes a variety of inhaler types, ranging from a single dose device suitable for applications such as immunizations, to a multi-unit dose suitable for
The study will be conducted as a randomized, double-blinded, placebo-controlled Phase II trial for prevention of acute and chronic allograft nephropathy at the University of Cairo. The aim
According to the company, the software, MIRA-ECHO, enables cardiac echocardiography (ECHO) images to be viewed, measured and interpreted in clinical trials and is the latest addition to Icon
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.